[NDRA] YoY Quarter Result on 31-Mar-2017 [#Q1]

Stock
[NDRA] ENDRA Life Sciences Inc.
Announcement Date
21-Jun-2017
Financial Year
2017
Quarter
31-Mar-2017 [#Q1]
Profit Trend
QoQ- -8.01%
YoY- -95.78%
Quarter Report
NDRA's Result
NDRA's Financial Summary
View:
Show?
Quarter Result
31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 CAGR
Revenue 0 0 0 6 0 0 414 -
PBT -2,269 -3,323 -2,749 -2,825 -742 -379 -564 26.08%
Tax 121 235 0 0 381 6 0 -
NP -2,269 -3,323 -2,749 -2,825 -742 -379 -564 26.08%
Tax Rate - - - - - - - -
Total Cost 2,269 3,323 2,749 2,831 742 379 978 15.04%
Ratio Analysis
31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 CAGR
NP Margin 0.00 0.00 0.00 -45,761.31 0.00 0.00 -136.01 -
Per Share
31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 CAGR
EPS -1.20 -5.77 -7.41 -14.40 -3.80 -1.94 -18.79 -36.75%
EPS Diluted -1.20 -5.77 -7.41 -14.40 -3.80 -1.94 -18.40 -36.52%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.